These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22826519)

  • 1. New horizons in sedative hypnotic drug development: fast, clean, and soft.
    Johnson KB
    Anesth Analg; 2012 Aug; 115(2):220-2. PubMed ID: 22826519
    [No Abstract]   [Full Text] [Related]  

  • 2. Remimazolam: new beginnings or just a me-too?
    Sneyd JR
    Anesth Analg; 2012 Aug; 115(2):217-9. PubMed ID: 22826518
    [No Abstract]   [Full Text] [Related]  

  • 3. Context sensitive decrement times of remimazolam.
    Schnider T; Minto C
    Anesth Analg; 2013 Jul; 117(1):285. PubMed ID: 23788743
    [No Abstract]   [Full Text] [Related]  

  • 4. Recirculatory pharmacokinetic modeling: what goes around, comes around.
    Krejcie TC; Avram MJ
    Anesth Analg; 2012 Aug; 115(2):223-6. PubMed ID: 22826520
    [No Abstract]   [Full Text] [Related]  

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and drug interactions of the sedative hypnotics.
    Wang JS; DeVane CL
    Psychopharmacol Bull; 2003; 37(1):10-29. PubMed ID: 14561946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of time-dependent inactivation on the estimation of enzyme kinetic parameters for midazolam.
    Giragossian C; LaPerle J; Kosa RE; Gillian S
    Drug Metab Lett; 2009 Jan; 3(1):45-53. PubMed ID: 19356116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol reduces the distribution and clearance of midazolam.
    Lichtenbelt BJ; Olofsen E; Dahan A; van Kleef JW; Struys MM; Vuyk J
    Anesth Analg; 2010 Jun; 110(6):1597-606. PubMed ID: 20435936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetic monitoring of midazolam in critically ill patients.
    Spina SP; Ensom MH
    Pharmacotherapy; 2007 Mar; 27(3):389-98. PubMed ID: 17316150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of midazolam in infants and children.
    Blumer JL
    Clin Pharmacokinet; 1998 Jul; 35(1):37-47. PubMed ID: 9673833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology.
    Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD
    Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypnotic and sedative drugs--anything new on the horizon?
    Gin T
    Curr Opin Anaesthesiol; 2013 Aug; 26(4):409-13. PubMed ID: 23820101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A maturation model for midazolam clearance.
    Anderson BJ; Larsson P
    Paediatr Anaesth; 2011 Mar; 21(3):302-8. PubMed ID: 20704661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peculiarities of hypnotic effect and pharmacokinetics of hemisuccinate 3-hydroxyphenazepam (levana)].
    Voronina TA; Larionov VB; Golovenko NIa; Nerobkova LN
    Eksp Klin Farmakol; 2014; 77(1):3-6. PubMed ID: 24649593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS 7056: a novel ultra-short-acting Benzodiazepine.
    Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
    Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.